General Information:
Id: | 7,531 (click here to show other Interactions for entry) |
Diseases: |
Diabetes mellitus, type II
- [OMIM]
Insulin resistance |
Homo sapiens | |
review | |
Reference: | Muller TD et al.(2017) The New Biology and Pharmacology of Glucagon Physiol. Rev. 97: 721-766 [PMID: 28275047] |
Interaction Information:
Comment | Several lines of evidence indicate that glucagon enhances metabolic rate through activation of brown adipose tissue (BAT). Oxygen consumption and BAT temperature increase in rats following glucagon administration, and glucagon stimulates oxygen consumption in BAT-derived cells. Plasma levels of glucagon increase in rats and humans upon cold exposure, and cold-acclimatized rats have increased levels of glucagon in both plasma and BAT. Administration of norepinephrine increases BAT glucagon levels, and pretreatment of rats or hamsters with the beta-adrenergic receptor blocker propranolol blocks glucagon’s thermogenic effect. |
Formal Description Interaction-ID: 75376 |
drug/chemical compound increases_quantity of gene/protein |